Africa: Vaccines Deliver Over U.S.$30 Billion in Economic Benefits for Lower-Income Countries in 2025

What the report says

Gavi said its vaccine programmes generated more than US$30 billion in economic benefits in 2025, according to its annual progress report published in Geneva. The gains, the alliance said, came from lower healthcare costs, fewer illnesses and deaths, reduced disability, and longer-term benefits such as better educational outcomes and a more productive workforce.

The report also said lower-income countries contributed a record US$301 million in co-financing for Gavi-supported vaccines in 2025. Gavi described this as part of a broader shift in which countries gradually take on a larger share of vaccine costs as their economies grow. It added that countries’ contributions over the past five years matched the total they paid across the previous 13 years combined.

Gavi said its supported programmes vaccinated more than 73 million children in 2025 and helped prevent more than 2.2 million future deaths, both annual records. Over the 2021–2025 strategic period, the alliance said it reached more than 351 million children, above its target of 300 million, and prevented more than 7.8 million future deaths.

The organisation, which works with partners including UNICEF and the World Health Organization, said it is entering a new strategic phase focused on reaching more children, including those in conflict-affected and humanitarian settings. It also said it is still working to raise funds for 2026–2030 while seeking to protect 500 million more children and generate more than US$100 billion in economic benefits over that period.